Table 2.
Outcomes at discharge and treatment complications in stroke patients who received EVT stratified by severity and intravenous (IV) Alteplase use.
|
Short-term Outcomes and Treatment Complications |
EVT Patients NIHSS ≤5 |
EVT patients NIHSS >5 |
||
|---|---|---|---|---|
|
Without IV Alteplase (n=311) |
With IV Alteplase (n=135) |
Without IV Alteplase (n=1931) |
With IV Alteplase (n=1409) |
|
| Discharge home/rehab, % | 232 (74.6) | 106 (78.5) |
934 (48.4) |
834 (59.2) |
|
Independent ambulation, % |
153 (62.2) |
67 (69.8) |
405 (29.1) |
361 (37.8) |
| Symptomatic ICH, % | 13(4.2) | 7 (5.2) |
123 (6.4) |
92 (6.5) |
| Life threatening or serious systemic hemorrhage, % | 2 (0.6) | 1 (0.7) |
20 (1.0) |
11 (0.8) |
| Death, % | 16 (5.1) | 7 (5.2) | 238 (12.3) | 137 (9.7) |